Thermo Fisher ( NYSE: TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data ...
Companies this past month announced many new products and services that use artificial intelligence to automate complex ...
"With our new AI-native clinical encounter, we're ushering in a new era where technology fades into the background. It listens to the visit, understands the context, and engages in real time - so ...
The Global Healthcare Analytics Market is poised for exponential expansion, rising from USD 42.96 billion in 2024 to USD ...
Altamont Software, a provider of enterprise medical connectivity solutions, announces the availability of our Dynamic Content engine within Passport SR. This feature provides the ability to calculate ...
Anita Avers ”had a passion for counseling and believed that was her special gift she could give to others,” her obituary says ...
Genomics company Illumina (NASDAQ:ILMN) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were ...
In my conversations with ASC leaders this year, one theme has been impossible to miss: Change is everywhere. Centers are expanding, merging, modernizing, and rethinking how they use technology to ...
Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in ...
Life sciences group Thermo Fisher has sealed an all-cash takeover of drug trial software maker Clario in a deal that values ...
AI’s true power lies in pattern recognition across messy, real-world data: Natural language processing extracts phenotypes, comorbidities, and device usability feedback from unstructured clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results